Zimmer Biomet’s Mobi-C cervical disc prosthesis has become the most widely covered device for one- and two-level cervical disc replacement by commercial health insurers in the USA.
Mobi-C, acquired as part of Zimmer Biomet’s combination with LDR in July, is now accessible to more than 200 million insured patients with one-level disc disease and more than 150 million patients with two-level disc disease across more than 90 commercial insurance plans.
This milestone was achieved when Anthem (formerly WellPoint), which reports nearly 40 million enrolees in its health plans, added Mobi-C to the list of covered devices for one-level disc replacement and as the sole cervical total disc prosthesis covered for two-level surgery.
Mobi-C was the first cervical disc prosthesis approved by the US Food and Drug Administration (FDA) for reconstruction of the cervical disc at both one and two levels to treat arm pain and/or neurological deficit caused by various spine disorders or injuries. Mobi-C is a cobalt chromium alloy and polyethylene mobile-bearing prosthesis that is inserted in a single step, without requiring bone chiselling to accommodate vertebral anchorage such as screws or keels. Mobi-C features patented mobile-bearing technology designed to allow the prosthetic disc to self-adjust to facilitate motion similar to that of the natural cervical spine.